The global joint reconstruction devices market size reached US$ 26.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 36.5 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.
Joint reconstruction devices are primarily designed for restoring the movement of joints, providing them with structural support either temporarily or permanently, or aiding in tissue reconstruction. These devices are utilized separately or together with one or more implantable medical devices as a replacement in whole or part for shoulder, hip, or knee joints. Nowadays, joint disorders like osteoarthritis (OA) are widely becoming prevalent on account of sedentary lifestyles and unhealthy dietary patterns of individuals. This is positively influencing the requirement for joint reconstruction devices across the globe.
Joint Reconstruction Devices Market Trends:
The rising geriatric population around the world represents one of the key factors stimulating the growth of the market. Moreover, the advent of advanced, emerging technologies, such as 3D printing, robotics, and augmented reality (AR), are making joint reconstruction safer, more accurate, and efficient. 3D printing is increasingly being used in creating customized bio models (replicas of patient anatomy), devices, and implants to plan and simulate complex surgical procedures. This technology facilitates joint replacements associated with infection or the failure of a previous replacement joint. Besides this, robotic-assisted surgery is emerging as an innovative method for hip and knee arthroplasty as it offers enhanced component positioning, real-time information about soft tissue tensioning and balance, and restoration of hip length and offset. This, coupled with the increasing accidental or sports-related injuries that cause broken bones and dislocations, is strengthening the growth of the market. Apart from this, there is a rise in the number of individuals requiring total ankle replacement (TAR) and tibiotalar arthrodesis (TTA) for the surgical management of ankle arthritis, which is projected to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global joint reconstruction devicesmarket report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technique, joint type and end user.
Breakup by Technique:
Breakup by Joint Type:
Breakup by End User:
Ambulatory Surgical Centers (ASCs)
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aesculap Inc. (B. Braun Melsungen AG), Conformis Inc., Conmed Corporation, DJO Global Inc. (Enovis Corporation), Exactech Inc., Johnson & Johnson Services Inc, Kyocera Medical Technologies Inc. (Kyocera Corporation), Medacta International SA, Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.
Base Year of the Analysis
Technique, Joint Type, End User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Aesculap Inc. (B. Braun Melsungen AG), Conformis Inc., Conmed Corporation, DJO Global Inc. (Enovis Corporation), Exactech Inc., Johnson & Johnson Services Inc, Kyocera Medical Technologies Inc. (Kyocera Corporation), Medacta International SA, Smith & Nephew plc, Stryker Corporation and Zimmer Biomet
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global joint reconstruction devices market was valued at US$ 26.1 Billion in 2022.
We expect the global joint reconstruction devices market to exhibit a CAGR of 5.3% during 2023-2028.
The growing prevalence of joint disorders, such as osteoarthritis, along with rising number of accidental or sports-related injuries that cause broken bones and dislocations, is primarily driving the global joint reconstruction devices market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of numerous elective arthroplasty surgeries for reducing the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for joint reconstruction devices.
Based on the technique, the global joint reconstruction devices market has been segregated into joint replacement, osteotomy, arthroscopy, resurfacing, arthrodesis, and others. Among these, joint replacement currently holds the largest market share.
Based on the joint type, the global joint reconstruction devices market can be bifurcated into knee, hip, shoulder, ankle, and others. Currently, knee exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global joint reconstruction devices market include Aesculap Inc. (B. Braun Melsungen AG), Conformis Inc., Conmed Corporation, DJO Global Inc. (Enovis Corporation), Exactech Inc., Johnson & Johnson Services Inc, Kyocera Medical Technologies Inc. (Kyocera Corporation), Medacta International SA, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.